KZA 0.00% 8.0¢ kazia therapeutics limited

The best bit Our results suggest that TRX-E-002-1 may fill the...

  1. 1,300 Posts.
    lightbulb Created with Sketch. 6
    The best bit

    Our results suggest that TRX-E-002-1 may fill the current need for better therapeutic options in the control and management of recurrent ovarian cancer and may help improve patient survival.
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.